Study on bimatoprost eye solution vs tacrolimus ointment in treatment of stable vitiligo.
Phase 4
- Conditions
- Health Condition 1: L80- Vitiligo
- Registration Number
- CTRI/2024/01/061673
- Lead Sponsor
- Eras Lucknow Medical College and Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Stable vitiligo patients involving less than 5 % of body surface area attending the dermatology OPD at Era Lucknow Medical College and Hospital
Exclusion Criteria
1. Vitiligo patients who took treatment in last 3 months
2. Patient having hypersensitivity to tacrolimus ointment and bimatoprost ophthalmic solution.
3. Pregnant and lactating women
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To compare the therapeutic response of topical bimatoprost (0.03%) ophthalmic solution with tacrolimus (0.1%) ointment in cases of stable vitiligo.Timepoint: 0,4,8,12 weeks
- Secondary Outcome Measures
Name Time Method 1.To study the clinical response of bimatoprost (0.03%) ophthalmic solution on stable vitiligo. <br/ ><br>2.To study the clinical response of tacrolimus (0.1%) ointment on stable vitiligo. <br/ ><br>3.To identify any adverse effects associated with the use of topical bimatoprost (0.03%) ophthalmic solution and tacrolimus ointment (0.1%) in cases of stable vitiligo. <br/ ><br>Timepoint: 0,4,8,12 weeks